Cardinal Health, Inc. Shareholders: Ownership Structure, Brands, and Acquisition History
Last updated: Aug-2026Ownership Structure
Stakes approximate based on latest filings.
Ownership Analysis
Cardinal Health is a widely held public company with no family or founder control. Voting power follows economic ownership on a one-share one-vote basis, and the largest holders are the major index managers, Vanguard, BlackRock and State Street, whose positions reflect the company membership in the leading benchmarks.The company was founded in 1971 by Robert Walter, who built it into a distribution giant before stepping back, and it has been public since the early 1980s. A notable recent governance episode was a 2023 cooperation agreement with an activist investor that led to board additions and a review of the medical products business, illustrating shareholder influence.For investors the ownership structure means strategy is judged by the market, and the activist engagement accelerated Cardinal focus on its highest-return pharmaceutical distribution and specialty franchises. Leadership under chief executive Jason Hollar remains accountable to a dispersed base for improving margins and returns, particularly in the historically challenged medical products segment.
Direct Owners
Institutional Shareholders
Shareholder Analysis
Cardinal Health shareholder base is anchored by passive institutional capital. Vanguard, BlackRock and State Street hold the largest positions, driven by the company weight in the major indices, and together the big index families own a meaningful minority. Active investors and, in 2023, an activist have also shaped the register.Active investors own Cardinal Health for its cash generation and its recovery potential in medical products. In fiscal 2025 the company navigated the expiration of a large OptumRx distribution contract, yet grew GAAP earnings per share 87 percent to 6.45 dollars and non-GAAP earnings per share 9 percent to 8.24 dollars, driven by strong pharmaceutical and specialty segment profit. They focus on segment profit growth and free cash flow.Governance follows conventional norms with an independent board strengthened by the activist agreement. Because no controlling owner exists, capital return and margin improvement are the levers management uses to reward shareholders. The debate among owners has centered on the loss of the OptumRx contract, the recovery of the medical products business, and the returns from specialty acquisitions.
Brands, Subsidiaries & Companies Owned
| Name | Type | Description |
|---|
Portfolio Analysis
Cardinal Health competes through two main segments plus a set of growth businesses. Pharmaceutical and Specialty Solutions is the dominant franchise, distributing drugs and specialty products and generating the vast majority of revenue, and it has been the primary engine of profit growth.Global Medical Products and Distribution manufactures and distributes medical and surgical supplies, a business that struggled with inflation and cost pressures but has been the focus of a multi-year improvement effort. The two distribution franchises together give Cardinal broad reach across the healthcare supply chain.The growth businesses reported in Other, including Nuclear and Precision Health Solutions, at-Home Solutions and OptiFreight Logistics, are higher-margin and faster-growing, and Cardinal is expanding specialty physician services through acquisitions in oncology and urology. The portfolio strategy leans on pharmaceutical distribution for scale while growing specialty and the higher-margin growth businesses.
Market Share & Competitors
Bubble size reflects relative market share.
| Company | Market Share | Revenue | Key Strength |
|---|
Competitive Analysis
Cardinal Health is the third of the Big Three US pharmaceutical distributors, behind McKesson and Cencora, which together dominate the country drug supply. With fiscal 2025 revenue near 221 billion dollars, it is the smallest of the three but still an enormous, scaled distributor competing in a concentrated industry.Its competitive edge is distribution scale and a growing set of specialty and higher-margin growth businesses. Unlike its peers, Cardinal also has a substantial medical products manufacturing and distribution business, which offers diversification but has been a source of margin pressure.The risks include the recent loss of a large OptumRx distribution contract, thin distribution margins, opioid-settlement obligations and the challenge of improving the medical products segment. Cardinal competitive answer is its scale, its specialty expansion, and the improvement program in medical products, which together aim to lift the margins and growth that the market and activists have demanded.
Acquisitions
Bubble size reflects relative deal value.
| Company Acquired | Deal Value | Year | Description |
|---|
Acquisitions Analysis
Cardinal Health has used acquisitions to build distribution scale historically and, recently, to expand into specialty physician services. Its history includes large medical-products deals, some of which proved challenging, and the company has at times taken impairments on acquired businesses.The recent focus is specialty. In 2024 Cardinal acquired Specialty Networks, a specialty group purchasing and data business, and Integrated Oncology Network, expanding its community oncology reach. In 2025 it acquired a controlling interest in Solaris Health, a national urology physician services organization, for roughly 1.9 billion dollars.The acquisition philosophy has shifted toward higher-margin specialty services that complement distribution and place Cardinal closer to specialty drug economics. These deals aim to diversify the company beyond low-margin wholesale distribution, addressing the growth and margin concerns that activist investors and the market have pressed.
Acquisition Timeline
Merger & Spin-off History
Merger & Spin-off Analysis
Cardinal Health structural history features both aggressive acquisition and a major spin-off. Founded in 1971 as a food distributor, it entered pharmaceutical distribution in 1979 and grew through a long series of acquisitions into one of the largest US distributors and a diversified healthcare company.The defining structural event was the 2009 spin-off of CareFusion, its medical technology business, which separated hospital products and technology into an independent company and refocused Cardinal on distribution and medical supplies. That divestiture reshaped the company scope.Recent structural moves have been specialty acquisitions rather than large spin-offs, including Specialty Networks, Integrated Oncology Network and Solaris Health. The pattern is one of building distribution scale, then reshaping through the CareFusion spin-off and a pivot toward specialty physician services to improve growth and margins.
Ownership History
Ownership History Analysis
Cardinal Health was founded in 1971 by Robert Walter as Cardinal Foods, a food distributor in Ohio, before pivoting into pharmaceutical distribution in 1979, a move that defined its future. Under Walter, the company grew rapidly through acquisitions into one of the largest distributors in the United States.Over the decades Cardinal expanded into medical products and hospital technology, then refocused by spinning off CareFusion in 2009. The company weathered opioid litigation and margin pressures in its medical products business, and in 2023 an activist campaign prompted governance changes and a sharper strategic focus.Today Cardinal Health is the third largest US pharmaceutical distributor, led by chief executive Jason Hollar, with fiscal 2025 revenue near 221 billion dollars and a growing specialty services business. Its history is one of transformation from a regional food distributor into a national healthcare distribution and services company.
Ownership Explained
Cardinal Health is a widely held public company listed on the New York Stock Exchange with no controlling shareholder. Its largest owners are index managers, led by Vanguard, BlackRock and State Street. Jason Hollar serves as chief executive officer. In 2023 the company reached a cooperation agreement with an activist investor that added independent directors, but no single owner controls the company.
With dispersed ownership and one-share one-vote governance, Cardinal Health answers fully to public shareholders and the capital markets. That accountability, sharpened by activist engagement in 2023, has driven a focus on the fast-growing Pharmaceutical and Specialty Solutions segment and on building specialty physician services. Management returns capital through dividends and buybacks. The absence of a controlling owner keeps strategy subject to market discipline.